RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
Xu Zhao(First Affiliated Hospital of Xi'an Jiaotong University), Xiaozhi Zhang(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 18
Related Papers
Epidemiologic trends of and factors associated with overall survival in patients with neuroendocrine tumors over the last two decades in the USA
|Endocrine Connections|2023|36
SOCS6 promotes radiosensitivity and decreases cancer cell stemness in esophageal squamous cell carcinoma by regulating c-Kit ubiquitylation
|Cancer Cell International|2021|23
DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis
|Scientific Reports|2021|19
Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment
|European journal of medical research|2024|19
Comprehensive Pan-Cancer Analysis of IRAK Family Genes Identifies IRAK1 as a Novel Oncogene in Low-Grade Glioma
|Journal of Oncology|2022|12